Cancer mutation study aims to match patients with targeted therapies
NCT ID NCT05489250
First seen Feb 05, 2026 · Last updated May 01, 2026 · Updated 12 times
Summary
This study looked at genetic changes in tumors from people with advanced gastrointestinal cancers, including liver, bile duct, gallbladder, pancreas, esophagus, and stomach cancers. The goal was to see how often these mutations occur and whether they can help doctors choose more personalized treatments. The study planned to enroll 565 participants but was stopped early.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Augusta-Kranken-Anstalt Bochum
Bochum, Germany
-
Bochum Uni
Bochum, Germany
-
CaritasKlinikum Saarbrücken
Saarbrücken, Germany
-
Ev. Kliniken Essen-Mitte, Klinik für Internistische Onkologie
Essen, 45136, Germany
-
Evangelisches Waldkrankenhaus Spandau
Berlin, Germany
-
Friedrich-Ebert-Krankenhaus Neumünster
Neumünster, Schleswig-Holstein, 24534, Germany
-
GEFOS - Gesellschaft für onkologische Studien Dortmund
Dortmund, Germany
-
HELIOS Klinikum Bad Saarow
Bad Saarow, Germany
-
Hamburg Onkologische Schwerpunktpraxis Eppendorf
Hamburg, Germany
-
KHNW Frankfurt
Frankfurt am Main, Hesse, 60488, Germany
-
Klinik München-Bogenhausen
München, Germany
-
Klinikum Chemnitz
Chemnitz, Germany
-
Klinikum Lippe
Lemgo, Germany
-
Klinikum Ludwigsburg
Ludwigsburg, Germany
-
Klinikum Rheine, Mathias-Spital Rheine
Rheine, Germany
-
Klinikum Wolfsburg
Wolfsburg, Germany
-
Krankenhaus Barmherzige Brüder
Regensburg, Germany
-
Langen, Gemeinschaftspraxis für Hämatologie und Onkologie
Langen, Germany
-
MVZ Onkologische Kooperation Harz
Goslar, Germany
-
MVZ Oskar-Helene-Heim Berlin
Berlin, Germany
-
Marien Hospital Witten
Witten, Germany
-
Medius Klinik Osterfildern-Ruit
Ostfildern, Germany
-
Münster, Gemeinschaftspraxis für Hämatologie und Onkologie
Münster, Germany
-
Onkologie Bodensee
Singen, Germany
-
Onkologisches Zentrum Wolfsburg-Helmstedt MVZ GmbH
Wolfsburg, Germany
-
Onkozentrum Dresden
Dresden, Germany
-
Ortenau Klinikum Lahr-Ettenheim
Lahr, Germany
-
St. Anna Hospital Herne
Herne, Germany
-
Studienzentrum UnterEms
Leer, Germany
-
Universitätsklinikum Halle (Saale)
Halle, Germany
-
ÜBAG - MVZ Dr. Vehling-Kaiser GmbH
Landshut, Germany
Conditions
Explore the condition pages connected to this study.